天津招聘

岗位职责：

1.Develop PSS and development strategy (including registration strategy) in collaboration with CD and RA dept；

2.Ensure best strategy to develop and launch product is considered from both clinical and regulatory perspective；

3.Conduct discussion with APGD AD and API RA for early stage products and provide local needs / requirements

4.Oversee individual project’s progress and quality to:

Ensure optimal actions are taken in individual projects to achieve successful launch of product

Handle issues and ensure any issues / topics are escalated appropriately to senior management；

5.Lead establishment / maintenance of knowledge management scheme related to product development and launch

6.Proactively share collected knowledge (e.g., lessons learned from past trial) with related members to further improve the organization / current process

7.Facilitate communication / collaboration within Medical and Development division as well as collaboration between API / APGD

8.Ensure implementation of compliance guidelines and regulations into all contracts

9.Join the discussion about training to CD and RA members to further improve functional capability

10.Support clinical trial and RA activities as required (e.g., SOP maintenance)

岗位要求：

1.Demonstrated communication, negotiation/influencing, and social skills with a sense of diplomacy, relating to peers.

2.Very good active and passive skills in English, leading and attending meetings, presenting and training.

3.Team player skills in a matrix organization and a track record of contributing to high quality results of teams.

4.Organization skills and inclined to set clear priorities on meeting targets with some experience in financial reporting and planning systems.

5.Working knowledge of China drug development processes.

6.Understanding the impact of regulatory requirements and guidances / internal SOPs / PM concepts.

7.Works effectively under pressure, accurate and patient.

8.Proficient in utilizing and creating outputs using relevant software. Easily adapts to change.

9.Suggestion: Internat travel several times a year; domestic travel 2-3 times per month

10.7+ yrs relevant R&D experience and 2+ yrs project management experience.

安斯泰来集团介绍：

安斯泰来制药集团是一家总部位于日本东京的研发型制药企业，在全球范围内研发、生产、销售创新型医药产品。我们的使命是不断提升企业价值，致力于通过创新可靠的医药产品为全世界人民的健康做贡献实现我们的存在意义。
安斯泰来制药集团已经在器官移植领域和泌尿领域成为全球专业治疗领域领导者（GCL）。我们结合自身的研发实力，锁定了五个重点研发领域，包括免疫/感染、泌尿、肿瘤、神经科学和糖尿病合并症/代谢性疾病。
在2010财务年度 (2010 年 4 月至 2011 年 3 月) 全球净销售额达 9539 亿日元（97 亿美元）。安斯泰来已经成为日本第二大处方药品公司，全世界排名 20位的制药企业。目前全球员工约 16000 人。 如欲了解更多详细信息，请登录安斯泰来集团全球网站***********************/en/。

安斯泰来中国介绍：
安斯泰来制药（中国）有限公司（以下简称“安斯泰来中国”）是由原“山之内制药（中国）有限公司”于2005年8月更名，再于2007年4月1日，与“藤泽药品（中国）有限公司”合并而成。
安斯泰来中国以“通过提供创新而可靠的医药产品为世界人民的健康做贡献”为经营理念，秉持高度的伦理观和道德观，开展合乎法规的经营活动。在提升企业价值的使命下，发挥创造性，实现业务的持续发展，力图在中国成为受到客户、员工、相关企业、社会团体等利益相关者信赖的企业。
安斯泰来中国是安斯泰来制药集团在中国投资的全资子公司。工厂位于沈阳经济开发区，总部设在北京，在上海、北京、广州、成都、武汉、青岛和沈阳设有分公司，业务范围遍及全国大中城市，全国约有员工1000名。
安斯泰来中国目前在中国上市销售9个产品，涉及器官移植、泌尿、感染、皮肤、消化循环等多个专业领域，其中已经在器官移植和泌尿领域得到广大医生和患者的认可，处于市场领先地位。如欲了解更多详细信息，请登录安斯泰来中国网站**************************.